Business

Jaguar Health Announces Incorporation of Napo EU Subsidiary in Italy

Napo EU will serve as the foundation of the Company's efforts to address the growing burden - particularly in Europe - of the inflammatory diarrhea associated

articleJaguar Health, Inc.March 15, 20213/company/jaguar-animal-health-inc/news/jaguar-health-announces-incorporation-of-napo-eu-subsidiary-in-italy
Jaguar Health Announces Incorporation of Napo EU Subsidiary in Italy

About this update from Jaguar Health, Inc.

[{"type":"text","content":"Napo EU will serve as the foundation of the Company's efforts to address the growing burden - particularly in Europe - of the inflammatory diarrhea associated with long-hauler syndrome in the post COVID-19 patient populationIn honor of International Day of Forests, Company is conducting a survey contest to raffle off a signed print of an original painting of a Jaguar by Anthony J. Conte - link to entry form appears belowSAN FRANCISCO, CA / ACCESSWIRE / March 15, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) (\"Jaguar\" or the \"Company\"), today announced that Napo EU S.p.A. (\"Napo EU\"), a subsidiary of the Company in Italy, has been incorporated. Napo EU is the exclusive target of the planned Dragon special purpose acquisition company (the \"Dragon SPAC\"), which is anticipated to be listed on AIM Italia.\"We're thrilled to have established Napo EU in Italy - a necessary step as the exclusive target in the anticipated merger with the Italian Dragon SPAC. Napo EU will serve as the foundation of our efforts to address the growing burden - particularly in Europe - of the inflammatory diarrhea associated with long-hauler syndrome in the post COVID-19 patient population,\" stated Lisa Conte, Jaguar's founder, president, and CEO, \"and I am also pleased to announce that we have initiated the search process for qualified candidates to fill key management roles at Napo EU and are continuing the regulatory activities in support of seeking conditional marketing authorization from the European Medicines Agency (EMA).\"The terms \"long-hauler\" and \"chronic COVID\" refer to COVID-19 survivors who suffer with symptoms which may include gastrointestinal distress (i.e., diarrhea, constipation, nausea, pain), fatigue, brain fog, forgetfulness, cardiovascular effects, and arthritis, for an extended period after recovery. It is theorized that these symptoms may result when the immune system in COVID-19 survivors continues to overreact even though the infection has passed.Napo EU is located in Milan, which is also the Italian headquarters of the Company's secondary supplier of crofelemer, Indena S.p.A.International Day of Forests ContestIn honor of International Day of Forests - March 21, 2021 - Jaguar is conducting a survey contest to raffle off a signed print of an original painting of a Jaguar by Anthony J. Conte. The painting was inspired by a ...

More updates from Jaguar Health, Inc.